References
- Ohto H, Denomme GA, Ito S, Ishida A, Nollet KE, Yasuda H. Three non-classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti-Kell, anti-Ge3, anti-M, and anti-Jra cases. Transfus Aphers Sci 2020;59:102949. doi: 10.1016/j.transci.2020.102949.
- Zwiers C, Oepkes D, Lopriore E, Klumper FJ, de Haas M, van Kamp IL. The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization. Prenat Diagn 2018;38:943–50. doi: 10.1002/pd.5355.
- Kakaiya RM, Whaley A, Howard-Menk C, et al. Absence of hemolytic disease of fetus and newborn despite maternal high-titer IgG anti-Ku. Immunohematology 2010;26:119–23.
- Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IA. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798–803. doi: 10.1056/NEJM199803193381204.
- Brennand J. Middle cerebral ar tery Doppler. Australas J Ultrasound Med 2009;12:35–8. doi: 10.1002/j.2205-0140.2009.tb00058.x.
- Myle AK, Al-Khattabi GH. Hemolytic disease of the newborn: a review of current trends and prospects. Pediatric Health Med Ther 2021;12:491–8. doi: 10.2147/PHMT.S327032.
- Koelewijn JM, de Haas M, Vrijkotte TG, et al. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy. Transfusion 2008;48:1721–9.
- de Haas M, Thurik FF, Koelewijn JM, van der Schoot CE. Haemolytic disease of the fetus and newborn. Vox Sang 2015;109:99–113. doi: 10.1111/vox.12265.
- Harmening DM. Modern blood banking and transfusion practices. 7th ed. Philadelphia: FA Davis, 2019.
- Franklin IM. Prevention of rhesus haemolytic disease of the fetus and newborn. Lancet 2009;373:1082. doi: 10.1016/S0140-6736(09)60651-6.
- Caine ME, Mueller-Heubach E. Kell sensitization in pregnancy. Am J Obstet Gynecol 1986;154:85–90. doi: 10.1016/0002-9378(86)90398-4.
- Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247–52. doi: 10.1016/0002-9378(94)90477-4.
- Lydaki E, Nikoloudi I, Kaminopetros P, et al. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku. Transfusion 2005;45:1791–5. doi: 10.1111/j.1537-2995.2005.00604.x.